| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 01/15/2004 | WO2004005527A1 Microorganisms and processes for enhanced production of pantothenate |
| 01/15/2004 | WO2004005526A1 Process for producing phorenol |
| 01/15/2004 | WO2004005490A1 Novel baker’s yeast and bread using the same |
| 01/15/2004 | WO2004005311A1 Bafilomycin-like metabolite from a novel micromonospora species |
| 01/15/2004 | WO2003063783A3 Multiple virus replicon culture systems |
| 01/15/2004 | US20040009928 Isolation from a new marine microbe, strain PO13-046, belonging to the genus Actinomadura sp. |
| 01/15/2004 | US20040009579 Using microorganisms with restricted colonial and/or extensive hyphal branching phenotypes as bioreactors for expression of heterologous polypeptides |
| 01/15/2004 | US20040009575 Vibro expression vector for transferring heterologous nucleotide sequences into cells |
| 01/15/2004 | US20040009568 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 01/15/2004 | US20040009560 Directing the ration of B2:B1 avermectins in Streptomyces avermitilis host cells |
| 01/15/2004 | US20040009531 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 01/15/2004 | US20040009187 Rotavirus subunit vaccine |
| 01/15/2004 | US20040009179 Mycoplasma gallisepticum formulation |
| 01/15/2004 | CA2491137A1 Microorganisms and processes for enhanced production of pantothenate |
| 01/15/2004 | CA2489761A1 Process for producing phorenol |
| 01/14/2004 | EP1380652A1 Process for producing acrylamide using microbial catalyst having been washed with aqueous acrylic acid solution |
| 01/14/2004 | EP1380650A1 Conditionally replicating viral vectors and their use |
| 01/14/2004 | EP1380648A2 Recombinant DNAase B derived from streptococcus pyogenes |
| 01/14/2004 | EP1380645A2 Production in bacteria ad yeast of hemoglobin and analogues thereof |
| 01/14/2004 | EP1379679A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 01/14/2004 | EP1379675A1 Method for the oxidation of aromatic compounds |
| 01/14/2004 | EP1379657A2 Disease-associated protein |
| 01/14/2004 | EP1379641A2 Process for the production and purification of secreted proteins and the production of arrays of proteins |
| 01/14/2004 | EP1379637A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 01/14/2004 | EP1379272A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/14/2004 | EP0832229B1 Cd40l mutein |
| 01/14/2004 | CN1134539C Thrombopoietin |
| 01/14/2004 | CN1134538C Fy7 polymerase |
| 01/14/2004 | CN1134266C Methods for inducing T cell tolerance to tissue or organ graft |
| 01/14/2004 | CN1134214C Method of biological control |
| 01/13/2004 | US6677301 Epithelial cell proliferation stimulants; wound healing agents |
| 01/13/2004 | US6677149 Storing microorganisms with preferential enzymatic activity; obtain microorganisms, incubate in storage solution, monitor microorganisms for preferential enzymatic activity |
| 01/13/2004 | US6677145 Isolating a nucleotide sequence having specific sequence, constructing a vector consists of an isolated nucleotide sequence operably linked to a promoter, introducing the vector into host cell for expression of elongase enzyme |
| 01/13/2004 | US6677142 Chain extension of glucosyl group acceptor with sucrose in presence of amylosucrase and fructose; low polydispersity |
| 01/13/2004 | US6677136 Glucagon antagonist domain, preferably having very little or no glucagon agonist activity, yeast-based screening phage display, rna- peptide screening, etc. attached to a vehicle, e.g., an fc domain, peg or dextran |
| 01/13/2004 | US6677134 Generation of zeaxanthin by fermentation; obtain cells, transform with vector, express vector, incubate with farnesyl pyrophosphate, recover zeaxanthin |
| 01/13/2004 | US6677127 Nucleic acid respiratory syncytial virus vaccines |
| 01/13/2004 | US6677124 Monoclonal antibody recognizing C-terminus of hBNP |
| 01/13/2004 | US6676949 Two-step immunization procedure against Chlamydia infection |
| 01/13/2004 | US6676945 Induction immunology response |
| 01/13/2004 | US6676924 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| 01/08/2004 | WO2004002223A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/08/2004 | WO2003020876A3 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006026 For use as antibiotics, in therapy of infectious diseases |
| 01/08/2004 | US20040005692 Comprises nucleotide sequences coding amidase (AMDS) for use as diagnostic tool in genetic engineering |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005325 Helicobacter felis vaccine |
| 01/08/2004 | US20040005323 Efficient method for generating human antibodies in particular which are specific to be RSV fusion protein which combines in vitro primary of human spleen cells and antigen boosting in SCID mice is taught. This method provides for very high human |
| 01/08/2004 | US20040005303 In vivo induction for enhanced function of isolated hepatocytes |
| 01/08/2004 | DE10225117A1 Verfahren zur Herstellung von konjugierter Linolsäure Process for the preparation of conjugated linoleic acid |
| 01/08/2004 | CA2486543A1 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/07/2004 | EP1378574A1 Enhanced production of taxol and taxanes by cell cultures of taxus species |
| 01/07/2004 | EP1378573A1 Interleukin 1 beta protease and interleukin 1 beta protease inhibitors |
| 01/07/2004 | EP1378572A1 Bmp-11 compositions |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378569A1 Method of extracting virus gene and extraction apparatus |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378522A2 Methods of enhancing bioactivity of chemokines |
| 01/07/2004 | EP1378245A2 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine |
| 01/07/2004 | EP1377662A2 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa) |
| 01/07/2004 | EP1377608A1 Insulin precursors and a process for their preparation |
| 01/07/2004 | EP1021556B1 Assay using marked microbial host cell strains |
| 01/07/2004 | EP0722500B1 Genes for butyrobetaine/crotonobetaine-l-carnitine metabolism and their use for the microbiological production of l-carine |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | EP0551386B1 Methods for treating cotton-containing fabrics with cellulase |
| 01/07/2004 | CN1466628A A method of extracellular production of target proteins employing OmpF in e coli |
| 01/07/2004 | CN1466626A Production process of subtilin surfactin |
| 01/07/2004 | CN1466625A Method of proliferating natural killer cells |
| 01/07/2004 | CN1133598C Water purifying agent and water purifying method |
| 01/07/2004 | CN1133437C Nocathiacin antibiotics |
| 01/06/2004 | US6673990 Biopesticides |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673610 Mutating nucleotide sequences; obtain nucleotide sequence, incubate with mutant primers and polymerase, amplify nucleotide sequence, digest recover product, screen for primer sequences |
| 01/06/2004 | US6673607 Cryogenic stabilization of cells; obtain cells, inject with cryogenic agent, activate latent state, store cells |
| 01/06/2004 | US6673600 Transgenic C. elegans as a model organism for investigations on Alzheimer's disease |
| 01/06/2004 | US6673591 Increasing permissiveness of cell to viral replication by decreasing expression of interferon by making cell deficient in factor that regulates interferon expression in vivo |
| 01/06/2004 | US6673590 Multiply-substituted protease variants with altered net charge for use in detergents |
| 01/06/2004 | US6673583 Recombinantly producing levodione reductase |
| 01/06/2004 | US6673573 Expression of immunoglobulin-cytokine fusion proteins in malignant B cells |
| 01/06/2004 | US6673569 Dsb protein family, includes dsba (formation of) and dsbc (isomerizing of) disulfide bonds, and dsbb or dsbd to control the reactivity of dsba/dsbc; use to study coexpression effects of these proteins in secretion of a foreign protein |
| 01/06/2004 | US6673349 Crosslinking; forming vaccines |
| 01/06/2004 | CA2142712C Bordetella bronchiseptica vaccine |
| 01/06/2004 | CA2135083C Antibodies to p-selectin and their uses |
| 01/06/2004 | CA2134094C Production of recombinant human lactoferrin |
| 01/06/2004 | CA2128208C Novel seven transmembrane receptors |
| 01/06/2004 | CA2086681C Growth promoting agent derived from milk |
| 01/06/2004 | CA2080573C Novel bioprocesses for preparing 7-aca and 7-adac |
| 01/02/2004 | EP1375677A1 Probes for detecting and identifying helicobacter pylori |
| 01/02/2004 | EP1375664A1 Method for the sectetion and production of protein |
| 01/02/2004 | EP1375655A1 Method for producing l-leucine |
| 01/02/2004 | EP1375520A1 Apoptosis induced by monoclonal antibody anti-Her2 |
| 01/02/2004 | EP1374910A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/02/2004 | EP1374879A1 Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
| 01/02/2004 | EP1373513A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/02/2004 | EP1373511A2 Genes and proteins, and their uses |
| 01/02/2004 | EP1373506A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 01/02/2004 | EP1373497A2 Method for increasing the production of a secondary metabolite in a microorganism by introducing mutations that confer antibiotic-resistance |
| 01/02/2004 | EP1373480A2 Uncoupled productive and catabolic host cell pathways |